Trial CRAD001C2454

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

CRAD001C2454

Full title

Multizentrische, einarmige, zweistufige Phase-II-Studie mit RAD001 (Everolismus) mit Glivec bei Glivec-resistenten Patienten mit progressivem GIST

EudraCT number

2005-004837-16

NCT number

NCT00510354

Responsible organization

Medizinische Klinik III, Telefon: 089440072551

Classification	Code	Description
-		Gastrointestinal tumors

Trial type

Interventional

Blinding type

Open

Phase

Status

Trial finished

Votes

Institutional review board - vote

Unknown

Initiiation & lock

Date of lock (planned / actual)

2012-11-30 / 2013-07-02

	Function	Prename	Surname	Organization
	Principal Investigator	Lars	Lindner	Keine Organisationseinheit angegeben